![]() |
||||||||
|
Orchid Chemicals & Pharmaceuticals Ltd |
||||||||
|
Unaudited Financial Results for the year ended December
31, 2001
|
||||||||
|
Rs.Lakhs
|
||||||||
| Sl No | Particulars |
Three months ended
Dec 31, 2001 (Unaudited) |
Three months ended
Dec 31, 2000 (Unaudited) |
Six months ended
Dec 31, 2001 (Unaudited) |
Six months ended
Dec 31, 2000 (Unaudited) |
Year Ended
March 31,2001 (Audited) |
||
|
1
|
Sales and Operating Income |
9571.68
|
9019.06
|
27834.87
|
27053.63
|
37124.92
|
||
|
2
|
Other Income |
18.86
|
25.04
|
56.44
|
109.33
|
131.22
|
||
|
3
|
Total Expenditure |
7621.81
|
6722.17
|
21280.29
|
19995.77
|
27450.85
|
||
| a) Decrease/(Increase) in Stock in trade |
(574.49)
|
(378.63)
|
(443.99)
|
(1870.37)
|
(3753.92)
|
|||
| b) Consumption of raw materials |
5075.77
|
4634.26
|
13476.84
|
14793.23
|
21129.43
|
|||
| c) Staff Cost |
639.22
|
541.60
|
1778.89
|
1467.31
|
2188.42
|
|||
| d) Other Expenditure |
2481.31
|
1924.94
|
6468.55
|
5605.60
|
7886.92
|
|||
|
4
|
Profit Before Interest, Depreciation &
Tax (1+2-3) |
1968.73
|
2321.93
|
6611.02
|
7167.19
|
9805.29
|
||
|
5
|
Interest and Finance Charges |
710.31
|
702.23
|
2508.09
|
2220.98
|
3043.20
|
||
|
6
|
Depreciation |
880.54
|
806.19
|
2557.01
|
2325.69
|
3116.31
|
||
|
7
|
Profit Before Tax (4-5-6) |
377.88
|
813.50
|
1545.92
|
2620.51
|
3645.78
|
||
|
8
|
Provision for Taxation | |||||||
| Current Tax |
0.00
|
0.00
|
0.00
|
70.04
|
70.04
|
|||
| Deferred Tax |
152.74
|
217.02
|
503.38
|
888.72
|
0.00
|
|||
|
9
|
Net Profit (7-8) |
225.14
|
596.48
|
1042.54
|
1661.75
|
3575.74
|
||
|
10
|
Paid- up Equity Share Capital (Face value of Rs. 10 each) |
2799.92
|
2799.92
|
2799.92
|
2799.92
|
2,799.92
|
||
|
11
|
Reserves excluding Revaluation Reserves |
--
|
--
|
36964.65
|
||||
|
12
|
Earnings per share (EPS) Rs. |
0.80 **
|
2.13 **
|
3.72 **
|
5.93 **
|
12.77
|
||
| *EPS is for the period (not annualised ) after providing for deferred tax. | ||||||||
Segmentwise Revenue, Results and Capital Employed |
||||||||
Three months ended 31-Dec-01 |
Nine Months ended 31-Dec-01 |
|||||||
| 1. Segment Revenue | ||||||||
| a. Bulk | 9275.30 |
26952.48 |
||||||
| b. Formulations |
562.49
|
1619.75
|
||||||
| Total |
9837.79
|
28572.23
|
||||||
| Less : Inter segment revenue |
266.11
|
737.36
|
||||||
| Net Sales / Income from Operations |
9571.68
|
27834.87
|
||||||
| 2. Segment Results | ||||||||
| a. Bulk |
1190.02
|
4534.64
|
||||||
| b. Formulations |
(75.15)
|
(401.20)
|
||||||
| Total |
1114.87
|
4133.44
|
||||||
| Less : i) Interest (Net) |
710.31
|
2508.09
|
||||||
| ii) Other unallocable expenditure net off unallocable income |
26.68
|
79.43
|
||||||
| Total Profit Before Tax |
377.88
|
1545.92
|
||||||
| 3. Capital Employed | ||||||||
| a. Bulk |
59830.71
|
59830.71
|
||||||
| b. Formulations |
1877.51
|
1877.51
|
||||||
| Total |
61708.22
|
61708.22
|
||||||
|
||||||||
|
||||||||